A rating of 59 puts Ligand Pharmaceuticals Inc. (LGND) near the middle of the Biotechnology industry according to InvestorsObserver. Ligand Pharmaceuticals Inc.'s score of 59 means it scores higher than 59% of stocks in the industry. Ligand Pharmaceuticals Inc. also received an overall rating of 52, putting it above 52% of all stocks. Biotechnology is ranked 28 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 52 means the stock is more attractive than 52 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Ligand Pharmaceuticals Inc. Stock Today?
Ligand Pharmaceuticals Inc. (LGND) stock has gained 0.88% while the S&P 500 has fallen -0.55% as of 2:08 PM on Tuesday, Sep 29. LGND is higher by $0.84 from the previous closing price of $95.75 on volume of 165,398 shares. Over the past year the S&P 500 has gained 11.98% while LGND has fallen -2.96%. LGND lost -$1.38 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Ligand Pharmaceuticals Inc. (LGND) Stock.
